Spermatogenesis and Semen Disorders
6
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Composition for Treating Spermatogenesis and Semen Disorders / FPT-20
Power Prenatal Supplements for Sperm Quality
Prospective Study on Power Prenatal Vitamins for Males on YO Score At-home Sperm Test Results
The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility
Effects of Procyanidine on Semen Parameters and DNA Fragmentation Index During Cryopreservation of Abnormal Human Semen Samples
In Vitro Effects of Procyanidine on Semen Parameter and DFI